Cite
HARVARD Citation
Kennedy, G. et al. (n.d.). A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia. British journal of haematology. pp. 794-801. [Online].